What is myoclonus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Myoclonus in comatose survivors of cardiac arrest is a significant predictor of poor outcome, particularly when it presents as status myoclonus within 48 hours of return of spontaneous circulation (ROSC) 1.

Clinical Presentation and Prognosis

Myoclonus refers to brief, involuntary muscle jerks or twitches that occur suddenly, caused by rapid muscle contractions. In the context of cardiac arrest, myoclonus can be a symptom of various neurological disorders, including post-anoxic encephalopathy. The presence of myoclonic jerks in comatose survivors of cardiac arrest is not consistently associated with poor outcome, with a false positive rate (FPR) of 9% 1. However, status myoclonus, defined as a prolonged period of continuous and generalized myoclonic jerks, is highly predictive of poor outcome, with an FPR of 0% in both non-TTM-treated and TTM-treated patients 1.

Diagnosis and Treatment

Diagnosis of myoclonus and status myoclonus is primarily clinical, based on observation of the patient's motor activity. Electroencephalography (EEG) can be useful in identifying EEG signs of awareness and reactivity, as well as coexistent epileptiform activity 1. Treatment of myoclonus and status myoclonus is challenging, and may involve the use of antimyoclonic drugs such as clonazepam, sodium valproate, and levetiracetam 1. Propofol has also been shown to be effective in suppressing post-anoxic myoclonus 1.

Key Considerations

  • Status myoclonus within 48 hours of ROSC is a significant predictor of poor outcome in comatose survivors of cardiac arrest 1.
  • EEG can be useful in identifying EEG signs of awareness and reactivity, as well as coexistent epileptiform activity 1.
  • Treatment of myoclonus and status myoclonus is challenging, and may involve the use of antimyoclonic drugs and propofol 1.
  • Prolonged observation may be necessary after treatment of seizures to determine the patient's prognosis 1.

From the Research

Myoclytic Disorders

  • Myoclonus is a sudden, brief, involuntary muscle jerk, caused by abrupt muscle contraction or sudden cessation of ongoing muscular activity 2
  • It can be classified based on the underlying physiology, which is useful for therapeutic purposes 2
  • The diagnosis of myoclonus involves taking a good history, clinically characterizing the myoclonus, and looking for additional findings on examination to limit the list of possible investigations 2

Causes and Related Conditions

  • Rhabdomyolysis is a clinical syndrome of muscle injury associated with myoglobinuria, electrolyte abnormalities, and often acute kidney injury (AKI) 3
  • Exertional rhabdomyolysis is characterized by muscle breakdown associated with strenuous exercise or normal exercise under extreme circumstances 4
  • Myopathy can be reversible, as seen in cases of rhabdomyolysis caused by statins 5

Treatment and Management

  • Treatment of rhabdomyolysis aims at discontinuation of further skeletal muscle damage, prevention of acute renal failure, and rapid identification of potentially life-threatening complications 3
  • Early and aggressive fluid resuscitation is agreed on as the main intervention for preventing and treating AKI in rhabdomyolysis 3
  • Myoclonus treatment often requires polytherapy with a combination of drugs, including antiepileptic drugs and clonazepam 2
  • Focal and segmental myoclonus may be treated with botulinum toxin injections, with variable success 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Myoclonic disorders: a practical approach for diagnosis and treatment.

Therapeutic advances in neurological disorders, 2011

Research

Rhabdomyolysis.

Chest, 2013

Research

[Rhabdomyolysis and acute renal failure secondary to statins].

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.